Literature DB >> 8430278

Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats.

B S Dunjic1, J Axelson, A Ar'Rajab, K Larsson, S Bengmark.   

Abstract

Phosphatidylcholine (PC) is a main component of the hydrophobic gastric mucosal barrier. Exogenously administered, it prevents acute lesions. We evaluated the gastroprotective capacity of exogenous PC in both acute (ethanol- and indomethacin-induced) and chronic (indomethacin-induced) lesions in rats. Polyunsaturated (PPC) or hydrogenated PC in different concentrations were given intragastrically, before or after the injury factor, in single or repeated doses. Mucosal lesions were significantly reduced by a single dose of PPC, given before or after the injury factor, in both acute models. In the chronic model a single dose of PPC or hydrogenated PC significantly reduced lesions evaluated 6 h after ulcer induction, whereas after 72 h no protective effect was noticed. Repeated doses of PC were ineffective. In conclusion, in acute models exogenous PC reduces lesions in a dose-dependent manner and contributes to the mucosal defense. In chronic models an incomplete and temporary protection might be due to complex pathogenesis that requires activation of all levels in the mucosal defense. Strengthening of only one level was insufficient to restrict injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430278     DOI: 10.3109/00365529309096051

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Helicobacter pylori: the primary cause of duodenal ulceration or a secondary infection?

Authors:  M Hobsley; F I Tovey
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Role of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments on rats.

Authors:  Frank I Tovey
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

3.  Orally administered phosphatidic acids and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice.

Authors:  Tamotsu Tanaka; Katsuya Morito; Masafumi Kinoshita; Mayumi Ohmoto; Mai Urikura; Kiyoshi Satouchi; Akira Tokumura
Journal:  Dig Dis Sci       Date:  2012-11-18       Impact factor: 3.199

4.  Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress.

Authors:  Mika Adachi; Gou Horiuchi; Natsuki Ikematsu; Tamotsu Tanaka; Junji Terao; Kiyoshi Satouchi; Akira Tokumura
Journal:  Dig Dis Sci       Date:  2011-02-06       Impact factor: 3.199

Review 5.  Phospholipids and lipid-based formulations in oral drug delivery.

Authors:  Gert Fricker; Torsten Kromp; Armin Wendel; Alfred Blume; Jürgen Zirkel; Herbert Rebmann; Constanze Setzer; Ralf-Olaf Quinkert; Frank Martin; Christel Müller-Goymann
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

6.  Anti-inflammatory effects of phosphatidylcholine.

Authors:  Irina Treede; Annika Braun; Richard Sparla; Mark Kühnel; Thomas Giese; Jerrold R Turner; Elsa Anes; Hasan Kulaksiz; Joachim Füllekrug; Wolfgang Stremmel; Gareth Griffiths; Robert Ehehalt
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

7.  TNF-alpha-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells.

Authors:  Irina Treede; Annika Braun; Petia Jeliaskova; Thomas Giese; Joachim Füllekrug; Gareth Griffiths; Wolfgang Stremmel; Robert Ehehalt
Journal:  BMC Gastroenterol       Date:  2009-07-13       Impact factor: 3.067

8.  Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.

Authors:  Gabor Eros; Saleh Ibrahim; Nikolai Siebert; Mihály Boros; Brigitte Vollmar
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

9.  Dietary Phytosterols Protective Against Peptic Ulceration.

Authors:  Frank I Tovey; Doga Capanoglu; G John Langley; Julie M Herniman; Serhat Bor; Omer Ozutemiz; Michael Hobsley; Karna Dev Bardhan; Bruno Linclau
Journal:  Gastroenterology Res       Date:  2011-07-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.